Tinea capitis: An update.
dermatophyte
fungal infection
ringworm
tinea capitis
Journal
Pediatric dermatology
ISSN: 1525-1470
Titre abrégé: Pediatr Dermatol
Pays: United States
ID NLM: 8406799
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
revised:
05
01
2022
received:
05
10
2021
accepted:
08
01
2022
pubmed:
26
1
2022
medline:
20
4
2022
entrez:
25
1
2022
Statut:
ppublish
Résumé
Tinea capitis is an important superficial infection and affects children globally. A literature review was conducted to identify recent findings and the current understanding of this fungal infection. Here, we highlight updates on important aspects of tinea capitis including advances in dermatophyte detection and diagnosis and comparing these new methods to more traditional techniques. Additionally, aspects of treating tinea capitis are discussed, including the importance of mycological confirmation and current means of treatment, and the treatment of asymptomatic carriers are reviewed. This review also examines the subject of laboratory monitoring of patients undergoing treatment with systemic antifungals; we discuss the opinions of prominent researchers and currently accepted guidelines. Lastly, we provide answers to several common questions that practitioners may encounter when treating a child with tinea capitis.
Substances chimiques
Antifungal Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
167-172Informations de copyright
© 2022 Wiley Periodicals LLC.
Références
Leung AKC, Hon KL, Leong KF, Barankin B, Lam JM. Tinea capitis: an updated review. Recent Pat Inflamm Allergy Drug Discov. 2020;14(1):58-68. doi:10.2174/1872213X14666200106145624
Rodríguez-Cerdeira C, Martínez-Herrera E, Szepietowski JC, et al. A systematic review of worldwide data on tinea capitis: analysis of the last 20 years. J Eur Acad Dermatol Venereol. 2021;35(4):844-883. doi:10.1111/jdv.16951
Gnat S, Łagowski D, Nowakiewicz A. Major challenges and perspectives in the diagnostics and treatment of dermatophyte infections. J Appl Microbiol. 2020;129(2):212-232. doi:10.1111/jam.14611
Fuller LC, Barton RC, Mohd Mustapa MF, Proudfoot LE, Punjabi SP, Higgins EM. British Association of Dermatologists’ guidelines for the management of tinea capitis 2014. Br J Dermatol. 2014;171(3):454-463. doi:10.1111/bjd.13196
Genedy RM, Sorour OA, Elokazy MAW. Trichoscopic signs of tinea capitis: a guide for selection of appropriate antifungal. Int J Dermatol. 2021;60(4):471-481. doi:10.1111/ijd.15289
Kupsch C, Gräser Y. The potential of molecular diagnostics in routine dermatology. In: Bouchara JP, Nenoff P, Gupta AK, Chaturvedi V, (Eds.). Dermatophytes and Dermatophytoses. Springer International Publishing; 2021:339-353. doi:10.1007/978-3-030-67421-2_16
Salehi Z, Shams-Ghahfarokhi M, Razzaghi-Abyaneh M. Molecular epidemiology, genetic diversity, and antifungal susceptibility of major pathogenic dermatophytes isolated from human dermatophytosis. Front Microbiol. 2021;12:643509. doi:10.3389/fmicb.2021.643509
Gnat S, Łagowski D, Nowakiewicz A, Dyląg M, Osińska M, Sawicki M. Detection and identification of dermatophytes based on currently available methods - a comparative study. J Appl Microbiol. 2021;130(1):278-291. doi:10.1111/jam.14778
Stein M, Tran V, Nichol KA, et al. Evaluation of three MALDI-TOF mass spectrometry libraries for the identification of filamentous fungi in three clinical microbiology laboratories in Manitoba, Canada. Mycoses. 2018;61(10):743-753. doi:10.1111/myc.12800
Sacheli R, Henri A, Seidel L, et al. Evaluation of the new Id-Fungi plates from Conidia for MALDI-TOF MS identification of filamentous fungi and comparison with conventional methods as identification tool for dermatophytes from nails, hair and skin samples. Mycoses. 2020;63(10):1115-1127. doi:10.1111/myc.13156
Gupta AK, Bamimore MA, Renaud HJ, Shear NH, Piguet V. A network meta-analysis on the efficacy and safety of monotherapies for tinea capitis, and an assessment of evidence quality. Pediatr Dermatol. 2020;37(6):1014-1022. doi:10.1111/pde.14353
Bortolussi R, Martin S, Audcent T, Barton M, Top K. Antifungal agents for common outpatient paediatric infections | Canadian Paediatric Society. https://www.cps.ca/en/documents/position/antifungal-agents-common-infections. Accessed August 30, 2021.
Patel D, Castelo-Soccio LA, Rubin AI, Streicher JL. Laboratory monitoring during systemic terbinafine therapy for pediatric onychomycosis. JAMA Dermatol. 2017;153(12):1326. doi:10.1001/jamadermatol.2017.4483
Li DG, Mostaghimi A. Utility of baseline transaminase monitoring during systemic terbinafine therapy for pediatric onychomycosis. JAMA Dermatol. 2018;154(5):626-627. doi:10.1001/jamadermatol.2018.0094
Wang Y, Lipner SR. Retrospective analysis of abnormal laboratory test results in pediatric patients prescribed terbinafine for superficial fungal infections. J Am Acad Dermatol. 2021;85(4):1042-1044. doi:10.1016/j.jaad.2021.01.073
Aleohin N, Bar J, Bar-Ilan E, Samuelov L, Sprecher E, Mashiah J. Laboratory monitoring during antifungal treatment of paediatric tinea capitis. Mycoses. 2021;64(2):157-161. doi:10.1111/myc.13197
Kimberlin DW, Brady MT, Jackson MA, Long SS, eds. Tinea capitis. In: Red Book: 2018-2021 Report of the Committee of Infectious Diseases. American Academy of Pediatrics; 2018:798-801.
Mayser P, Nenoff P, Reinel D, et al. S1 guidelines: tinea capitis. JDDG J Dtsch Dermatol Ges. 2020;18(2):161-179. doi:10.1111/ddg.14026
Brockman R, Funk T. Laboratory monitoring during treatment of onychomycosis in pediatric patients: a survey of provider perspectives and practices. Pediatr Dermatol. 2021;38(4):764-767. doi:10.1111/pde.14619
Kakourou T, Uksal U. Guidelines for the management of tinea capitis in children: management of tinea capitis. Pediatr Dermatol. 2010;27(3):226-228. doi:10.1111/j.1525-1470.2010.01137.x
Le TK, Cohen BA. Tinea capitis: advances and a needed paradigm shift. Curr Opin Pediatr. 2021;33(4):387-391. doi:10.1097/MOP.0000000000001034
Gupta AK, Renaud HJ, Quinlan EM, Shear NH, Piguet V. The growing problem of antifungal resistance in onychomycosis and other superficial mycoses. Am J Clin Dermatol. 2021;22(2):149-157. doi:10.1007/s40257-020-00580-6
Andersen PL, Jemec GB, Saunte DML. Treatment adherence and psychosocial impact of tinea capitis in families: qualitative pilot study. Dermatol Ther. 2020;33(4):e13570. doi:10.1111/dth.13570
Gupta AK, Foley KA, Versteeg SG. New Antifungal agents and new formulations against dermatophytes. Mycopathologia. 2017;182(1-2):127-141. doi:10.1007/s11046-016-0045-0
Foster KW, Friedlander SF, Panzer H, Ghannoum MA, Elewski BE. A randomized controlled trial assessing the efficacy of fluconazole in the treatment of pediatric tinea capitis. J Am Acad Dermatol. 2005;53(5):798-809. doi:10.1016/j.jaad.2005.07.028
Wu M, Lv T, Wang H. Successful photodynamic therapy of tinea capitis child with liver dysfunction caused by oral antifungal drugs: a case report. Photodiagnosis Photodyn Ther. 2020;30:101745. doi:10.1016/j.pdpdt.2020.101745
Aspiroz C, Melcon B, Cerro PA, Gilaberte Y. Tinea capitis caused by microsporum canis treated with methyl-aminolevulinate daylight photodynamic therapy and ketoconazole shampooing. Photodermatol Photoimmunol Photomed. 2021;37(6):567-568. doi:10.1111/phpp.12706
Aharaz A, Jemec GBE, Hay RJ, Saunte DML. Tinea capitis asymptomatic carriers: what is the evidence behind treatment? J Eur Acad Dermatol Venereol. 2021;35(11):2199-2207. doi:10.1111/JDV.17462
Ginter-Hanselmayer G, Seebacher C. Treatment of tinea capitis - a critical appraisal. JDDG J Dtsch Dermatol Ges. 2011;9(2):109-114. doi:10.1111/j.1610-0387.2010.07554.x
Müller VL, Kappa-Markovi K, Hyun J, et al. Tinea capitis et barbae caused by Trichophyton tonsurans: a retrospective cohort study of an infection chain after shavings in barber shops. Mycoses. 2021;64(4):428-436. doi:10.1111/myc.13231